$BRZE
Braze, Inc. Stock $brze

$brze Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000167623822000019 Filed on June 14, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q2
Revenue	$77.50M	$70.43M	$47.88M
YoY Change	61.86%	64.07%	49.62%
Cost Of Revenue	$25.91M	$24.78M	$15.81M
YoY Change	63.89%	62.15%	33.96%
Gross Profit	$51.59M	$45.66M	$32.07M
YoY Change	60.86%	65.13%	58.76%
Gross Profit Margin	66.57%	64.83%	66.98%
Selling, General & Admin	$69.62M	$65.34M	$33.30M
YoY Change	109.08%	124.35%	59.32%
% of Gross Profit	134.95%	143.11%	103.83%
Research & Development	$21.62M	$22.90M	$11.80M
YoY Change	83.27%	154.49%	78.74%
% of Gross Profit	41.91%	50.16%	36.79%
Depreciation & Amortization	$1.000M	$650.0K	$600.0K
YoY Change	66.67%	-37.62%
% of Gross Profit	1.94%	1.42%	1.87%
Operating Expenses	$91.24M	$88.25M	$45.10M
YoY Change	102.32%	131.2%	63.98%
Operating Profit	-$39.65M	-$42.59M	-$13.03M
YoY Change	204.41%	304.91%	78.42%
Interest Expense	$456.0K	$362.0K	$32.00K
YoY Change	1325.0%	-1052.63%	-89.33%
% of Operating Profit
Other Income/Expense, Net	$30.00K		$32.00K
YoY Change	-6.25%
Pretax Income	-$39.62M	-$42.23M	-$12.99M
YoY Change	204.93%	300.02%	85.61%
Income Tax	$0.00	$1.117M	$200.0K
% Of Pretax Income
Net Earnings	-$39.27M	-$42.94M	-$12.83M
YoY Change	205.98%	307.2%	83.34%
Net Earnings / Revenue	-50.67%	-60.96%	-26.81%
Basic Earnings Per Share	-$0.42		-$0.65
Diluted Earnings Per Share	-$0.42	-$424.7K	-$0.65
COMMON SHARES
Basic Shares Outstanding	93.25M shares		19.67M shares
Diluted Shares Outstanding	93.25M shares		19.67M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$530.1M	$514.1M
YoY Change		494.24%
Cash & Equivalents	$90.61M	$478.9M	$48.20M
Short-Term Investments	$439.5M	$35.16M
Other Short-Term Assets	$7.636M	$4.688M
YoY Change		81.64%
Inventory
Prepaid Expenses
Receivables	$42.66M	$64.50M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$598.8M	$608.2M
YoY Change		354.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.497M	$7.393M
YoY Change		34.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.708M	$4.959M
YoY Change		933.13%
Total Long-Term Assets	$117.5M	$58.08M
YoY Change		55.14%
TOTAL ASSETS
Total Short-Term Assets	$598.8M	$608.2M
Total Long-Term Assets	$117.5M	$58.08M
Total Assets	$716.3M	$666.3M
YoY Change		288.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.680M	$2.083M
YoY Change		374.49%
Accrued Expenses	$33.23M	$25.47M
YoY Change
Deferred Revenue	$139.4M	$126.3M
YoY Change		68.82%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$181.0M	$160.0M
YoY Change		58.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$383.0K	$1.478M
YoY Change		-33.63%
Total Long-Term Liabilities	$383.0K	$1.478M
YoY Change		-33.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$181.0M	$160.0M
Total Long-Term Liabilities	$383.0K	$1.478M
Total Liabilities	$228.8M	$161.4M
YoY Change		56.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$254.2M	-$215.0M
YoY Change		55.5%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$484.7M	$501.6M	-$112.0M
YoY Change
Total Liabilities & Shareholders Equity	$716.3M	$666.3M
YoY Change		288.73%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q2
OPERATING ACTIVITIES
Net Income	-$39.27M	-$42.94M	-$12.83M
YoY Change	205.98%	307.2%	83.34%
Depreciation, Depletion And Amortization	$1.000M	$650.0K	$600.0K
YoY Change	66.67%	-37.62%
Cash From Operating Activities	$17.92M	-$24.53M	-$3.807M
YoY Change	-570.74%	318.67%
INVESTING ACTIVITIES
Capital Expenditures	$1.960M	-$1.423M	$298.0K
YoY Change	557.72%	-9.48%
Acquisitions
YoY Change
Other Investing Activities	-$405.5M	-$326.0K
YoY Change		-105.71%
Cash From Investing Activities	-$407.8M	-$1.749M	$17.15M
YoY Change	-2477.44%	-142.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.630M	463.3M	$1.965M
YoY Change	33.84%	10087.03%
NET CHANGE
Cash From Operating Activities	$17.92M	-24.53M	-$3.807M
Cash From Investing Activities	-$407.8M	-1.749M	$17.15M
Cash From Financing Activities	$2.630M	463.3M	$1.965M
Net Change In Cash	-$388.3M	437.0M	$15.18M
YoY Change	-2658.65%	15342.65%
FREE CASH FLOW
Cash From Operating Activities	$17.92M	-$24.53M	-$3.807M
Capital Expenditures	$1.960M	-$1.423M	$298.0K
Free Cash Flow	$15.96M	-$23.11M	-$4.105M
YoY Change	-488.82%	439.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001676238
CY2022Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2022Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q2	dei	Amendment Flag AmendmentFlag	false
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P4Y
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P4Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	716298000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	666262000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P4Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P4Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P4Y
CY2022Q2	dei	Document Type DocumentType	10-Q
CY2022Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q2	dei	Document Period End Date DocumentPeriodEndDate	2022-04-30
CY2022Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	dei	Entity File Number EntityFileNumber	001-41065
CY2022Q2	dei	Entity Registrant Name EntityRegistrantName	Braze, Inc.
CY2022Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2505271
CY2022Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	330 West 34th Street
CY2022Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Floor 18
CY2022Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2022Q2	dei	City Area Code CityAreaCode	609
CY2022Q2	dei	Local Phone Number LocalPhoneNumber	964-0585
CY2022Q2	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
CY2022Q2	dei	Trading Symbol TradingSymbol	BRZE
CY2022Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q2	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q2	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90610000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	478937000	USD
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	646000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	743000	USD
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	42663000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64504000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	439486000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	35156000	USD
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26006000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29588000	USD
CY2022Q2	us-gaap	Assets Current AssetsCurrent	598765000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	608185000	USD
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	4036000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	4036000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9497000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7393000	USD
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54804000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2022Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	44488000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	41689000	USD
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4708000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4959000	USD
CY2022Q2	us-gaap	Assets Assets	716298000	USD
CY2022Q1	us-gaap	Assets Assets	666262000	USD
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2680000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2083000	USD
CY2022Q2	brze	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	28870000	USD
CY2022Q1	brze	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	31623000	USD
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	139437000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	126260000	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9992000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	180979000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	159966000	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	47392000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	383000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1478000	USD
CY2022Q2	us-gaap	Liabilities Liabilities	228754000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	161444000	USD
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2871000	USD
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3235000	USD
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	741291000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	717175000	USD
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2397000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-640000	USD
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-254230000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-214961000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	484673000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	501583000	USD
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93250000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93250000	shares
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	77495000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47877000	USD
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	25906000	USD
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	15807000	USD
CY2022Q2	us-gaap	Gross Profit GrossProfit	51589000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	32070000	USD
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46044000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24351000	USD
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21620000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11797000	USD
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23574000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8947000	USD
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	91238000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	45095000	USD
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-39649000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13025000	USD
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000	USD
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39619000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12993000	USD
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	160000	USD
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-39633000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-13153000	USD
CY2022Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-364000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-319000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-39269000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-12834000	USD
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	588000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19669000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19669000	shares
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-39633000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-13153000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-562000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-130000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1195000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-40000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1757000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-170000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-41390000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13323000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-364000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-319000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41026000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13004000	USD
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3235000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	501583000	USD
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2630000	USD
CY2022Q2	brze	Apic Share Based Payment Arrangement Option Early Exercised Increase For Cost Recognition APICShareBasedPaymentArrangementOptionEarlyExercisedIncreaseForCostRecognition	54000	USD
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17172000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1757000	USD
CY2022Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-364000	USD
CY2022Q2	brze	Stock Issued During Period Value Charitable Donation StockIssuedDuringPeriodValueCharitableDonation	-4260000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-39269000	USD
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2871000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	484673000	USD
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	62831000	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	174229000	USD
CY2021Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2233000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-108507000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2432000	USD
CY2021Q2	brze	Apic Share Based Payment Arrangement Option Early Exercised Increase For Cost Recognition APICShareBasedPaymentArrangementOptionEarlyExercisedIncreaseForCostRecognition	115000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6967000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-170000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-319000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-12834000	USD
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	62831000	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	174229000	USD
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1914000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-111997000	USD
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-39633000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-13153000	USD
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	16971000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	6956000	USD
CY2022Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	5407000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3800000	USD
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	965000	USD
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-143000	USD
CY2021Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-210000	USD
CY2022Q2	us-gaap	Noncash Contribution Expense NoncashContributionExpense	4260000	USD
CY2021Q2	us-gaap	Noncash Contribution Expense NoncashContributionExpense	0	USD
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13000	USD
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	160000	USD
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-505000	USD
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-75000	USD
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4000	USD
CY2021Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1000	USD
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21984000	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8355000	USD
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3615000	USD
CY2021Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1576000	USD
CY2022Q2	brze	Increase Decrease In Capitalized Contract Cost Net IncreaseDecreaseInCapitalizedContractCostNet	8205000	USD
CY2021Q2	brze	Increase Decrease In Capitalized Contract Cost Net IncreaseDecreaseInCapitalizedContractCostNet	5666000	USD
CY2022Q2	brze	Capital Expenditures Incurred But Not Yet Paid Changes To Property Plant And Equipment Costs CapitalExpendituresIncurredButNotYetPaidChangesToPropertyPlantAndEquipmentCosts	623000	USD
CY2021Q2	brze	Capital Expenditures Incurred But Not Yet Paid Changes To Property Plant And Equipment Costs CapitalExpendituresIncurredButNotYetPaidChangesToPropertyPlantAndEquipmentCosts	-49000	USD
CY2022Q2	brze	Increase Decrease In Right Of Use Assets And Liabilities IncreaseDecreaseInRightOfUseAssetsAndLiabilities	-879000	USD
CY2021Q2	brze	Increase Decrease In Right Of Use Assets And Liabilities IncreaseDecreaseInRightOfUseAssetsAndLiabilities	0	USD
CY2022Q2	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-614000	USD
CY2021Q2	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1892000	USD
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	28000	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	119000	USD
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2530000	USD
CY2021Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7463000	USD
CY2022Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	13177000	USD
CY2021Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6157000	USD
CY2022Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	10000	USD
CY2021Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-58000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17921000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3807000	USD
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1960000	USD
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	298000	USD
CY2022Q2	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	306000	USD
CY2021Q2	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	498000	USD
CY2022Q2	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	421537000	USD
CY2021Q2	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8059000	USD
CY2022Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	16000000	USD
CY2021Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	26008000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-407803000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17153000	USD
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2630000	USD
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2184000	USD
CY2022Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	219000	USD
CY2022Q2	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	0	USD
CY2021Q2	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	0	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2630000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1965000	USD
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1075000	USD
CY2021Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-134000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-388327000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15177000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	482973000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33018000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94646000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48195000	USD
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	172000	USD
CY2021Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022Q2	brze	Share Based Payment Arrangement Amount Capitalized To Internal Use Software ShareBasedPaymentArrangementAmountCapitalizedToInternalUseSoftware	232000	USD
CY2021Q2	brze	Share Based Payment Arrangement Amount Capitalized To Internal Use Software ShareBasedPaymentArrangementAmountCapitalizedToInternalUseSoftware	11000	USD
CY2022Q2	brze	Capital Expenditures Incurred But Not Yet Paid Capitalized Internal Use Software Costs CapitalExpendituresIncurredButNotYetPaidCapitalizedInternalUseSoftwareCosts	21000	USD
CY2021Q2	brze	Capital Expenditures Incurred But Not Yet Paid Capitalized Internal Use Software Costs CapitalExpendituresIncurredButNotYetPaidCapitalizedInternalUseSoftwareCosts	-56000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-1195000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-40000	USD
CY2022Q2	brze	Vesting Of Stock Options Early Exercised VestingOfStockOptionsEarlyExercised	54000	USD
CY2021Q2	brze	Vesting Of Stock Options Early Exercised VestingOfStockOptionsEarlyExercised	115000	USD
CY2022Q2	us-gaap	Settlement Of Asset Retirement Obligations Through Noncash Payments Amount SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount	365000	USD
CY2021Q2	us-gaap	Settlement Of Asset Retirement Obligations Through Noncash Payments Amount SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount	0	USD
CY2022Q2	brze	Stock Options Receivables Acquired StockOptionsReceivablesAcquired	0	USD
CY2021Q2	brze	Stock Options Receivables Acquired StockOptionsReceivablesAcquired	245000	USD
CY2022Q2	brze	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
CY2021Q2	brze	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	224000	USD
CY2022Q2	us-gaap	Nature Of Operations NatureOfOperations	Company Overview<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Description of Business</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Braze, Inc., together with its subsidiaries (collectively, the “Company”, “we”, “us”, “our” or “Braze”), is a cloud-based customer engagement platform that delivers customer-centric experiences across push notifications, email, in-product messaging, SMS and MMS messages, and more. Customers use the Braze platform to facilitate real-time experiences between brands and customers in a more authentic and human way.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We began operations in 2011 and are incorporated in the state of Delaware. Our headquarters are located in New York, New York. We also lease additional office space in Austin, Berlin, Chicago, London, San Francisco, Singapore, and Tokyo.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Emerging Growth Company Status</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and, for so long as we continue to be an emerging growth company, we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. In addition, pursuant to Section 107 of the JOBS Act, as an emerging growth company, we have elected to take advantage of the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies. If we cease to be an emerging growth company, we will no longer be able to take advantage of these exemptions or the extended transition period for complying with new or revised accounting standards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Impact of COVID-19</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in January 2020, the outbreak of the novel Coronavirus Disease 2019 (“COVID-19”) pandemic caused general business disruption worldwide. COVID-19 is considered to be highly contagious and poses a serious public health threat. Although certain restrictions are being lifted, state mandated lockdowns have adversely impacted many companies in the past, as many public health regulations transformed or even halted daily operations, and similar adverse effects may re-occur if any state mandated lockdowns are reinstated in the future. We have not experienced a materially negative impact from COVID-19 and continue to monitor the global situation and the potential impact on our financial condition, liquidity, operations, suppliers, industry, and workforce. Given the continued evolution of the COVID-19 outbreak, including the emergence of new variant strains of COVID-19, and the global responses to curb its spread, we are not able to estimate the ongoing effects on our results of operations, financial condition, or liquidity.</span></div>
CY2022Q2	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications and immaterial changes have been made to prior-period financial statements to conform to the current-period presentation.</span></div>
CY2022Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5600000	USD
CY2022Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2200000	USD
CY2022Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reported period. We evaluate estimates based </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on historical and anticipated results, trends, and various other assumptions. Significant items subject to such estimates and assumptions include but are not limited to the standalone selling price for separate performance obligations in our revenue arrangements, expected period of benefit for deferred contract costs, the valuation of common stock and stock-based compensation, the incremental borrowing rate for operating leases, the allocation of overhead costs between cost of revenue and operating expenses, the estimated useful lives of intangible and depreciable assets, the valuation of deferred tax assets and liabilities and other tax estimates including our ability to utilize net operating losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments as facts and circumstances dictate. As future events and their effects, including the uncertainty surrounding rapidly changing market and economic conditions from the outbreak of COVID-19, cannot be determined with precision, actual results could differ from those estimates and many of our estimates and assumptions have required increased judgement and carry a higher degree of variability and volatility.</span></div>
CY2022Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable securities and accounts receivable. Restricted cash consists of letters of credit related to our leased properties. For cash, cash equivalents, restricted cash, and marketable securities, we are exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the consolidated balance sheets in excess of federal insurance limits. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant customers are those which represent 10% or more of our total revenue for the period, or accounts receivable at the balance sheets dates. For the three months ended April 30, 2022 and April 30, 2021, no customer accounted for 10% or more of our total revenue.</span></div>For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheets.
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47877000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59600000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	61300000	USD
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	77495000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47877000	USD
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	77495000	USD
CY2022Q2	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	500000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	800000	USD
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	59500000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	35900000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	743000	USD
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-143000	USD
CY2022Q2	brze	Accounts Receivable Allowance For Credit Loss Charge To Deferred Revenue AccountsReceivableAllowanceForCreditLossChargeToDeferredRevenue	164000	USD
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	137000	USD
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	19000	USD
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	646000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	249600000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	163700000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	85900000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	268200000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	180500000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	87700000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	304000000.0	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	199100000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	104900000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	373600000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	237800000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	135800000	USD
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	390900000	USD
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	255100000	USD
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	135800000	USD
CY2022Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	500000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	500000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29588000	USD
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3235000	USD
CY2022Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-364000	USD
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2871000	USD
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	33336000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	439486000	USD
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	472822000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	439627000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	35156000	USD
CY2022Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	474783000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	440708000	USD
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	16000	USD
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1238000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	439486000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	35183000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	27000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	35156000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	1300000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	100000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	security
CY2022Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	267854000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	267605000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	439486000	USD
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	600000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	172854000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	171881000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	440708000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	33671000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	33646000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1512000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1510000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	35183000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	35156000	USD
CY2022Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	443000	USD
CY2021Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	223000	USD
CY2022Q2	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	13000	USD
CY2021Q2	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-160000	USD
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	456000	USD
CY2021Q2	us-gaap	Investment Income Net InvestmentIncomeNet	63000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15587000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12622000	USD
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6090000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5229000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9497000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7393000	USD
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000000	USD
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26006000	USD
CY2022Q2	brze	Prepaid Software PrepaidSoftware	12531000	USD
CY2022Q1	brze	Prepaid Software PrepaidSoftware	19396000	USD
CY2022Q2	us-gaap	Prepaid Advertising PrepaidAdvertising	1192000	USD
CY2022Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	704000	USD
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	3501000	USD
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	4372000	USD
CY2022Q2	brze	Prepaid Events Current PrepaidEventsCurrent	1146000	USD
CY2022Q1	brze	Prepaid Events Current PrepaidEventsCurrent	428000	USD
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	7636000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4688000	USD
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14269000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14075000	USD
CY2022Q2	brze	Accrued Software Subscriptions Current AccruedSoftwareSubscriptionsCurrent	2458000	USD
CY2022Q1	brze	Accrued Software Subscriptions Current AccruedSoftwareSubscriptionsCurrent	3217000	USD
CY2022Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	4060000	USD
CY2022Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	5961000	USD
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2451000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2218000	USD
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5632000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6152000	USD
CY2022Q2	brze	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	28870000	USD
CY2022Q1	brze	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	31623000	USD
CY2022Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1800000	USD
CY2021Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1200000	USD
CY2022Q2	brze	Common Stock Number Of Classes CommonStockNumberOfClasses	2	class
CY2022Q2	brze	Common Stock Threshold For Conversion Percentage Of Aggregate Shares Outstanding CommonStockThresholdForConversionPercentageOfAggregateSharesOutstanding	0.10
CY2022Q2	us-gaap	Noncash Contribution Expense NoncashContributionExpense	4300000	USD
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3116716	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	35.01
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	24.53
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	61764000	USD
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16971000	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6956000	USD
CY2022Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	232000	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	17203000	USD
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	6956000	USD
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	82930000	USD
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1300000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1300000	USD
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	3496000	USD
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	585000	USD
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	552000	USD
CY2022Q2	us-gaap	Lease Cost LeaseCost	4633000	USD
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	2499000	USD
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.054
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7274000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11413000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10695000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8422000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7446000	USD
CY2022Q2	brze	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	25165000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	70415000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12818000	USD
CY2022Q2	brze	Operating Lease Liability Tenant Improvement Allowance Not Yet Received OperatingLeaseLiabilityTenantImprovementAllowanceNotYetReceived	217000	USD
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	57380000	USD
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.012
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-39269000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-12834000	USD
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	93295000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	19928000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	45000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	259000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93250000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93250000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19669000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19669000	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13119000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	76797000	shares
CY2022Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	600000	USD
CY2021Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	200000	USD

Files In Submission

Name	View Source	Status
0001676238-22-000019-index-headers.html	Edgar Link	pending
0001676238-22-000019-index.html	Edgar Link	pending
0001676238-22-000019.txt	Edgar Link	pending
0001676238-22-000019-xbrl.zip	Edgar Link	pending
a20220430-brazeincxex311xq.htm	Edgar Link	pending
a20220430-brazeincxex312xq.htm	Edgar Link	pending
a20220430-brazeincxex32xq1.htm	Edgar Link	pending
brze-20220430.htm	Edgar Link	pending
brze-20220430.xsd	Edgar Link	pending
brze-20220430_cal.xml	Edgar Link	unprocessable
brze-20220430_def.xml	Edgar Link	unprocessable
brze-20220430_htm.xml	Edgar Link	completed
brze-20220430_lab.xml	Edgar Link	unprocessable
brze-20220430_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BRZE
Braze, Inc. Stock $brze

2022 Q2 Form 10-Q Financial Statement

#000167623822000019 Filed on June 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZE Braze, Inc. Stock $brze

2022 Q2 Form 10-Q Financial Statement

#000167623822000019 Filed on June 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZE
Braze, Inc. Stock $brze